Basel Medical Group Ltd (BMGL)
NasdaqCM: BMGL
· Precio en tiempo real · USD
4.51
-0.48 (-9.62%)
Al cierre: Aug 12, 2026, 3:58 PM
Basel Medical Group Ltd (BMGL) Stock Price, Analysis & Data
-9.62% (1D)
| Precio de compra | 3.53 |
| Capitalización de mercado | 7.06M |
| Ingresos (TTM) | 14.74M |
| Beneficio neto (TTM) | -10.05M |
| Beta | n/a |
| EPS (TTM) | -5.22 |
| Ratio PER (TTM) | n/a |
| Adelante PE | n/a |
| P/B (TTM) | 1.44 |
| P/S (TTM) | 0.48 |
| Earnings Date | n/a |
| Precio de venta | 5.68 |
| Volumen | 14,419 |
| Volumen medio (20D) | 62,650 |
| Abierto | 4.17 |
| Anterior Cerrar | 4.99 |
| Rango del día | 4.17 - 5.00 |
| Rango de 52 semanas | 4.17 - 25.80 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de BMGL
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services...
Industria Medical Care Facilities
Sector Healthcare
IPO Fecha Feb 25, 2025
Empleados 82
Bolsa de Valores NasdaqCM
Símbolo bursátil BMGL
Sitio web https://baselmedical.com
Desempeño financiero
En 2025, los ingresos de Basel Medical Ltd fueron 11.32M, un aumento de 12.63% en comparación con 10.05M del año anterior. Las ganancias fueron -10.64M, una disminución de -613.11%.
Estados financieros